Lutathera Clinical Development Timeline

 
• By Sue Sutter

Chronicle of the development and US FDA review of Advanced Accelerator Applications' lutetium Lu 177 dotatate for gastroenteropancreatic neuroendocrine tumors.

More from Drug Review Profiles

More from Product Reviews